File this under: "as plain as the nose on your face"

I just wonder if GW Pharmaceuticals is rooting for OWCP's tablet to shine in the safety and tolerability study. Buccal Sativex and OWCP's sublingual tablet........a natural marriage..........think about GW's resources..........they even have obtained an FDA approval. Could that seemingly unnecessary and redundant press release in late March be a whisper of things to come.